(Q40430180)

20 September 2017

title

Design, expression, and immunogenicity of a soluble HIV trimeric envelope fragment adopting a prefusion gp41 configuration (English)

1 reference

20 September 2017

4

David Montefiori

1 reference

20 September 2017

Zhi-Song Qiao

1

1 reference

20 September 2017

Mikyung Kim

2

1 reference

20 September 2017

Bruce Reinhold

3

1 reference

20 September 2017

Jia-huai Wang

5

1 reference

20 September 2017

Ellis L Reinherz

6

1 reference

20 September 2017

language of work or name

English

0 references

publication date

15 April 2005

1 reference

Journal of Biological Chemistry

20 September 2017

published in

1 reference

20 September 2017

volume

280

1 reference

20 September 2017

issue

24

1 reference

20 September 2017

page(s)

23138-23146

1 reference

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Mechanisms of viral membrane fusion and its inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Core structure of gp41 from the HIV envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Atomic structure of the ectodomain from HIV-1 gp41

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Atomic structure of a thermostable subdomain of HIV-1 gp41

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Structure of an unliganded simian immunodeficiency virus gp120 core

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Expression, purification, and characterization of recombinant HIV gp140. The gp41 ectodomain of HIV or simian immunodeficiency virus is sufficient to maintain the retroviral envelope glycoprotein as a trimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

A cdc15-like adaptor protein (CD2BP1) interacts with the CD2 cytoplasmic domain and regulates CD2-triggered adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Protein design of an HIV-1 entry inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Association of chemokine-mediated block to HIV entry with coreceptor internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Determination of disulfide bond assignments and N-glycosylation sites of the human gastrointestinal carcinoma antigen GA733-2 (CO17-1A, EGP, KS1-4, KSA, and Ep-CAM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Recognition by human monoclonal antibodies of free and complexed peptides representing the prefusogenic and fusogenic forms of human immunodeficiency virus type 1 gp41

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

A trimeric structural domain of the HIV-1 transmembrane glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Expression, purification, and characterization of gp160e, the soluble, trimeric ectodomain of the simian immunodeficiency virus envelope glycoprotein, gp160.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

The structural biology of type I viral membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Promoting trimerization of soluble human immunodeficiency virus type 1 (HIV-1) Env through the use of HIV-1/simian immunodeficiency virus chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

A chimeric protein of simian immunodeficiency virus envelope glycoprotein gp140 and Escherichia coli aspartate transcarbamoylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

A role for carbohydrates in immune evasion in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Antibody neutralization and escape by HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Additive Effects Characterize the Interaction of Antibodies Involved in Neutralization of the Primary Dualtropic Human Immunodeficiency Virus Type 1 Isolate 89.6

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Evolutionary dynamics of the glycan shield of the human immunodeficiency virus envelope during natural infection and implications for exposure of the 2G12 epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

The caveolin-1 binding domain of HIV-1 glycoprotein gp41 is an efficient B cell epitope vaccine candidate against virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Binding of the 2F5 monoclonal antibody to native and fusion-intermediate forms of human immunodeficiency virus type 1 gp41: implications for fusion-inducing conformational changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Capture of an early fusion-active conformation of HIV-1 gp41

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Construction of recombinant targeting immunogens incorporating an HIV-1 neutralizing epitope into sites of differing conformational constraint

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Epitope insertion into variable loops of HIV-1 gp120 as a potential means to improve immunogenicity of viral envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

Biophysical Characterization of gp41 Aggregates Suggests a Model for the Molecular Mechanism of HIV-associated Neurological Damage and Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414515200

21 January 2018

Identifiers

DOI

10.1074/JBC.M414515200

1 reference

20 September 2017

1 reference